Hugeraw Health Technology Co.,Ltd.
Products
Contact Us
  • Contact Person : Ms. mandy zhang
  • Company Name : Hugeraw Health Technology Co.,Ltd.
  • Tel : 86-523-51904695
  • Fax : --
  • Address : jiangsu,taizhou,Area A ,No. 1 pharmaceutical high tech Industrial Park,Yao Cheng Avenue,Taizhou ,China
  • Country/Region : China

Mesterolone CAS No: 1424-00-6

Mesterolone CAS No: 1424-00-6
Product Detailed
Related Categories:Pharmaceutical
Mesterolone CAS No: 1424-00-6 Molecular formula: C20H32O2 Molecular weight: 304.47 Appearance: White powder,soluble in acetone, ethanol, ethyl ether, ethyl acetate, insoluble in water. Assay: 99percent Delivery time: 5-7working days door to door Minimum order: 1g Supply ability: 100kg/month Quality standard: Enterprise standard Product Details: Mesterolone had seen widespread use in bodybuilding primarily for antiestrogenic activity in anabolic steroid stacks but such use has declined after introduction of aromatase inhibitors and SERMs. Most significant benefits of current Mesterolone use are considered to be maintaining libido off-cycle and also relatively and temporarily improving vascularity. Mesterolone is often used as an antiestrogenic treatment and may be used by those who have had a poor reaction to testosterone treatments. The drug has shown to be beneficial in treating sexual dysfunction, impotency and low libido. Mesterolone binds to estrogen receptors, reducing their activity, which not only reduces estrogen production, but also encourages natural testosterone production in the body. Mesterolone has shown value in treating men with mental health issues, such as depression, anxiety and bipolar disorders. The drug also is commonly used to treat sexual dysfunction, including low sperm count. Additionally, mesterolone may enhance the effectiveness of other steroids. Interestingly, unlike other steroids, the drug shows little value for bodybuilding, but has the same health risks involved in steroid use for that purpose.


Copyright Notice @ 2008-2022 ECBAY Limited and/or its subsidiaries and licensors. All rights reserved.